Sriam Labs Pvt Ltd - Company Review
Sriam Labs Pvt Ltd - Company ReviewSummary
Sriam Labs Pvt Ltd (Sriam Labs) is a manufacturer and marketer of pharmaceutical ingredients and intermediates. The company’s products portfolio includes biperidine hydrochloride, biperidine base, flavoxate hydrochloride, famciclovir, labetalol hydrochloride, memantine hydrochloride, moxifloxacin hydrochloride and trimipramine. It also undertakes complex chemical reactions and develops pharmaceutical intermediates as well as active pharmaceutical ingredients. The company markets its products to Switzerland, Mexico, Germany, Argentina, Singapore, Taiwan, South Africa, Canada, Brazil, Bangladesh, Malaysia, Spain, Dubai and Chile. Sriam Labs is headquartered in Hyderabad, Telangana, India.
This comprehensive company report of Sriam Labs Pvt Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.